Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Twist Bioscience collaborates with Berry Gene, will jointly develop a new portfolio of NGS products
This collaboration can provide a variety of NGS detection solutions

Twist Bioscience, a provider of high quality synthetic DNA through a silicon platform company, today announced a partnership with China's leading Berry Gene, a supplier of high-throughput sequencing (NGS) in China, has reached a strategic cooperation and will add Twist's NGS targeted enrichment and library preparation tools to its products, aiming to promote the high-standard development of precision medical in vitro diagnostics in China.

This product combines Berry Gene's expertise in genomics and high-throughput sequencing (NGS), as well as Twist Bioscience's large-scale manufacturing capabilities, and can provide a variety of NGS detection solutions. The combined product aims to provide researchers with high-quality tools for better application in the screening of tumours and genetic diseases.

"We are very happy to cooperate with Berry Gene, which is one of the most popular and leading companies in the gene sequencing industry in China," said Dr Emily M. Leproust, CEO and co-founder of Twist Bioscience. "Berry has extensive experience in transforming genetic testing technology into clinical applications and has achieved remarkable results. In recent years, Berry Gene has been at the forefront of using NGS to detect diseases and is committed to making more Chinese people enjoy To the health benefits of gene sequencing technology. Twist is honoured to add our NGS solution to Berry Gene’s products."

The NGS products provided by Twist are unique in that they have unparalleled uniformity and have all been quality-verified (QC). The new product will provide Berry Gene with the highest-quality NGS product portfolio today, which will further promote the high-standard development of precision medical in vitro diagnostics in China.

Berry Gene and Twist Bioscience will work closely to develop a more innovative and cutting-edge NGS product portfolio to maintain a leading position in the diagnosis and screening of genetic diseases, and provide Berry Gene with more, better and timely Research and IVD solutions.

Every oligonucleotide of Twist has been verified by NGS to ensure the accuracy of each probe sequence and the presence of all probes in the delivered probe pool, which will further improve the accuracy of our products. We are very I am glad to add Twist NGS series products to our product line. "Dr Zhou Daixing, general manager of Berry Gene said.

Tags : #TwistBioscience #LatestNewsonTwistBioscience22ndFeb #BerryGene #LatestNewsonBerryGene22ndFeb #LatestPharmaNews22ndFeb #LatestPharmaCollaboration22ndFeb #LatestNewsonGeneticDiseases #China

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026